Obstructive Sleep Apnea-Hypopnea Syndrome in a Patient with Severe Psychopathology

被引:1
|
作者
Konstantinou, Gerasimos N. [1 ]
Vlachos, Themistocles K. [1 ]
Stogioglou, Dimitrios G. [1 ]
Vasilopoulou, Polyxeni P. [1 ]
机构
[1] 251 Hellen Air Force Gen Hosp, Dept Psychiat, Athens, Greece
关键词
D O I
10.3928/00485713-20200627-01
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
A 46-year-old man with severe obesity (body mass index [BMI] of 52 kg/m2) was admitted for hospitalization in the psychiatric department of a general hospital because of behavioral disorders and constant suicidal and homicidal ideation. The patient had posted a threatening message on a social media network about his manager at work after a conflict between them, stating that he had “a specific plan to harm either himself or his manager.” Initial evaluation included a semi-structured diagnostic interview by a clinical psychiatrist, the Hamilton Depression Scale-21 items test (HAMD-21) (score of 27), the Hamilton Anxiety Scale (HAM-A) (score of 26), the Montreal Cognitive Assessment (MoCA) (score of 22), and the Brief Psychiatric Rating Scale (BPRS) (score of 96). At the time of the initial psychiatric assessment, the patient presented with poor insight and judgment. He was confused, irritated, suspicious, and incapable of describing his feelings. He had a remarkable dysfunction in emotional awareness, social attachment, and interpersonal relating (all of which are core characteristics of alexithymia). The patient's colleagues who accompanied him to the hospital reported that the patient presented with high levels of anxiety, psychomotor agitation, social withdrawal, poor personal hygiene, and constant suicidal and homicidal ideation in the last 20 days before his admission, and that the symptoms had been gradually worsening. Laboratory test results revealed moderate liver damage and hyperlipidemia, with a serum aspartate aminotransferase level of 47 U/L (normal range, 13-30 U/L), total cholesterol level of 267 mg/dL (normal range <200 mg/dL), and triglyceride level of 258 mg/dL (normal range, 40–150 mg/dL). He had remarkably high blood pressure (210/130 mm Hg). Drug test results were negative, and magnetic resonance imaging showed no pathological signs. He had been diagnosed previously with hypertension and had a history of two previous hospitalizations in a psychiatric department because of depressive symptoms and suicidal ideation. In the past, he had refused any medication for hypertension or for the psychiatric symptoms. Six years ago, he had also been diagnosed with alopecia areata related to high levels of anxiety. © SLACK Incorporated.
引用
收藏
页码:365 / 368
页数:4
相关论文
共 50 条
  • [21] Evaluation of Meibomian Glands in Obstructive Sleep Apnea-Hypopnea Syndrome
    Muhafiz, Ersin
    Olcen, Merhamet
    Erten, Remzi
    Bozkurt, Erdinc
    [J]. CORNEA, 2020, 39 (06) : 685 - 690
  • [22] Potential inflammatory markers in obstructive sleep apnea-hypopnea syndrome
    Lu, Dongmei
    Li, Nanfang
    Yao, Xiaoguang
    Zhou, Ling
    [J]. BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2017, 17 (01) : 47 - 53
  • [23] Small airways' function in Obstructive Sleep Apnea-Hypopnea Syndrome
    Giannadaki, K.
    Schiza, S.
    Vavougios, G.
    Ladopoulos, V.
    Tzanakis, N.
    Siafakas, N.
    [J]. PULMONOLOGY, 2021, 27 (03): : 208 - 214
  • [24] Prevalence of hyperuricemia in patients with obstructive sleep apnea-hypopnea syndrome
    Banno, K
    Shiomi, T
    Sasanabe, R
    Yamakawa, H
    Otake, K
    Hasegawa, R
    Wakayama, H
    [J]. SLEEP, 2003, 26 : A225 - A226
  • [25] Neuropsychological profiles in levels of obstructive sleep apnea-hypopnea syndrome
    Naksidil Torun-Yazihan
    Hamdullah Aydin
    Sirel Karakas
    [J]. Sleep and Biological Rhythms, 2007, 5 : 85 - 94
  • [26] Prevalence of floppy eyelid syndrome in obstructive sleep apnea-hypopnea syndrome
    Karger, R. A.
    Woog, J. J.
    Olson, E. J.
    [J]. SLEEP, 2006, 29 : A216 - A216
  • [27] Atrial overdrive pacing for the obstructive sleep apnea-hypopnea syndrome
    Simantirakis, EN
    Schiza, SE
    Chrysostomakis, SI
    Chlouverakis, GI
    Klapsinos, NC
    Siafakas, NM
    Vardas, PE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (24): : 2568 - 2577
  • [28] Neuropsychological profiles in levels of obstructive sleep apnea-hypopnea syndrome
    Torun-Yazihan, Naksidil
    Aydin, Hamdullah
    Karakas, Sirel
    [J]. SLEEP AND BIOLOGICAL RHYTHMS, 2007, 5 (02) : 85 - 94
  • [29] Nocturia in Obstructive Sleep Apnea-Hypopnea Syndrome: An Underappreciated Symptom
    Aristide, Guy
    Weinstein, Michael
    Nair, Girish B.
    [J]. CURRENT RESPIRATORY MEDICINE REVIEWS, 2013, 9 (03) : 217 - 224
  • [30] Prevalence of floppy eyelid syndrome in obstructive sleep apnea-hypopnea syndrome
    Karger, Randy A.
    White, W. Abraham
    Park, Won-Chan
    Rosales, A. Gabriela
    McLaren, Jay W.
    Olson, Eric J.
    Woog, John J.
    [J]. OPHTHALMOLOGY, 2006, 113 (09) : 1669 - 1674